Form D Explorer
CND Life Sciences, Inc. · CIK 1841099

Citable research briefCompare issuerPrivate research collection

CND Life Sciences, Inc.

CIK 1841099 · Corporation · Inc. DELAWARE · SCOTTSDALE, AZ · Biotechnology
https://cndlifesciences.com (possible website — auto-inferred, not verified)
Sign up to follow
Filings
5
Original notices
2
Amendments
3
Activity
Mar 6, 2025
through Aug 3, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 16, 2026 · DAug 3, 2026 · D/ALater minus earlier
Reported offering amount$6,250,000$6,316,514$66,514
Reported amount sold$4,314,750$6,316,514$2,001,764
Reported investor count11413
Reported minimum investment$25,000$25,000$0

Earlier SEC source: 0001841099-26-000001 · Later SEC source: 0001841099-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D/A · Aug 3, 2026

Reported offering amount
$6,316,514
Reported amount sold
$6,316,514

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (5)